RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
Simulating Multilevel Dynamics of Antimicrobial Resistance in a Membrane Computing Model
[EN] Membrane computing is a bio-inspired computing paradigm whose devices are the so-called membrane systems or P systems. The P system designed in this work reproduces complex biological landscapes in the computer world. It uses nested "membrane-surrounded entities" able to divide, propagate, and die; to be transferred into other membranes; to exchange informative material according to flexible rules; and to mutate and be selected by external agents. This allows the exploration of hierarchical interactive dynamics resulting from the probabilistic interaction of genes (phenotypes), clones, species, hosts, environments, and antibiotic challenges. Our model facilitates analysis of several aspects of the rules that govern the multilevel evolutionary biology of antibiotic resistance. We examined a number of selected landscapes where we predict the effects of different rates of patient flow from hospital to the community and vice versa, the cross-transmission rates between patients with bacterial propagules of different sizes, the proportion of patients treated with antibiotics, and the antibiotics and dosing found in the opening spaces in the microbiota where resistant phenotypes multiply. We also evaluated the selective strengths of some drugs and the influence of the time 0 resistance composition of the species and bacterial clones in the evolution of resistance phenotypes. In summary, we provide case studies analyzing the hierarchical dynamics of antibiotic resistance using a novel computing model with reciprocity within and between levels of biological organization, a type of approach that may be expanded in the multilevel analysis of complex microbial landscapes., This work was supported by the European Commission, Seven Framework Program (EVOTAR; FP7-HEALTH-282004) to F. Baquero, T. Coque, V. Fernandez-Lanza, and M. Campos; the Instituto de Salud Carlos III of Spain (Plan Estatal de I+D+i 2013-2016, grant PI15-00818 and FIS18-1942; CIBERESP, grant CB06/02/0053, and the EU Joint Programming Initiative JPIAMR2016-AC16/00036 to F. Baquero; the Regional Government of Madrid (InGEMICS-C; S2017/BMD-3691) to T. Coque and F. Baquero; and SAF2015-65878-R (MINECO, Spain) and PrometeoII/2014/065 (Generalitat Valenciana, Spain) to A. Moya (all cofinanced by the European Development Regional Fund [ERDF] "A Way to Achieve Europe").
Proyecto:
European Commission / FP7 282004
,
Ministerio de Economía y Competitividad SAF2015-65878-R
,
Ministerio de Economía y Competitividad PI15/00818
,
Generalitat Valenciana PROMETEOII/2014/065
,
Ministerio de Ciencia e Innovación FIS18-1942
,
Centro de Investigación Biomédica en Red en Bioingeniería CB06/02/0053
,
Biomateriales y Nanomedicina S2017/BMD-3691
,
Caja de Ahorros del Mediterráneo AC16/00036